Medication guide required by FDA for Vivitrol - ONA
Links shared publicly online about this topic.
- 1,192total visits
Medication guide required by FDA for Vivitrol - ONA
View full resource at oncologynurseadvisor.com
Tags: Drug, Healthcare, FDA
Most Recently Shared on May 4, 2010 at 9:24 pm By:
Medication guide required by FDA for Vivitrol http://goo.gl/fb/ac7Ad
Webicina.Com • Blog
webicina.com — “Webicina aims to help physicians enter the web 2.0 era with quality medical information and selected online medical resources.” View full resource at webicina.com
Most Recently Shared on December 15, 2011 at 6:06 pm By:
Curious abt @efpia response (if any) to @Berci SM Guide 4 Pharma http://t.co/5pT2EFYQ! http://t.co/AL8dZkql #efpia #hcsmeu #pharma #fda
Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)
fda.gov — “Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)” View full resource at fda.gov
Most Recently Shared on March 1, 2011 at 6:00 pm By:
New FDA Guidance about Med Guides http://cot.ag/hru9vf #fda #hcmktg
FDA warns about increased risk of thigh-bone fracture with bisphosphonates - - Drug Topics
drugtopics.modernmedicine.com — “FDA is requiring a labeling change and Medication Guide to warn patients and healthcare providers about the possible risk of atypical thigh-bone (femoral) fracture in patients who take bisphosphonates for the prevention and treatment of osteoporosis.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on November 16, 2010 at 5:07 am By:
FDA warns about increased risk of thigh-bone fracture with bisphosphonates: FDA is requiring a labeling ... http://bit.ly/cTktSi #pharma
FDA warns about increased risk of thigh-bone fracture with bisphosphonates - - Drug Topics
drugtopics.modernmedicine.com — “FDA is requiring a labeling change and Medication Guide to warn patients and healthcare providers about the possible risk of atypical thigh-bone (femoral) fracture in patients who take bisphosphonates for the prevention and treatment of osteoporosis.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on October 19, 2010 at 4:46 am By:
FDA warns about increased risk of thigh-bone fracture with bisphosphonates: FDA is requiring a labeling chang... http://bit.ly/bFIwJx #drug
FDA Alert: Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients
drugs.com — “FDA Alert: Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients” View full resource at drugs.com
Most Recently Shared on May 4, 2010 at 11:50 pm By:
FDA Alert - Vivitrol: Medication Guide Required for Patients - http://bit.ly/cWVMId
Medication guide required by FDA for Vivitrol - MPR
empr.com — “The FDA and Alkermes have notified healthcare professionals and patients of an update to the Warnings, Information for Patients, and Dosage and Administration sections of the Vivitrol (naltrexone injection) Prescribing Information to strengthen language regarding the risk of injection site reactions based on postmarketing reports that had been received prior to June 2009.” View full resource at empr.com
Most Recently Shared on May 4, 2010 at 9:52 pm By:
MPR News: Medication guide required by FDA for Vivitrol: The FDA and Alkermes have notified healthcare professiona... http://bit.ly/c5ZO44
FDA calls for labeling changes, medication guides for two topical testosterone gels
endocrinetoday.com — “The U.S. Food and Drug Administration today announced that it is requiring manufacturers of two prescription topical testosterone gel products,” View full resource at endocrinetoday.com
Most Recently Shared on May 11, 2009 at 2:15 pm By:
FDA calls for labeling changes, medication guides for two topical testosterone gels: http://tinyurl.com/test-gel
Advertisement

